Axsome Malta Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AXSOME MALTA, and what generic alternatives to AXSOME MALTA drugs are available?
AXSOME MALTA has one approved drug.
There are twenty-seven US patents protecting AXSOME MALTA drugs.
There are fifty-nine patent family members on AXSOME MALTA drugs in twenty-two countries and thirteen supplementary protection certificates in twelve countries.
Drugs and US Patents for Axsome Malta
International Patents for Axsome Malta Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 1890684 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2006133393 | ⤷ Try a Trial |
France | 20C1014 | ⤷ Try a Trial |
Brazil | 112019025286 | ⤷ Try a Trial |
Brazil | PI0613697 | ⤷ Try a Trial |
European Patent Office | 3630072 | ⤷ Try a Trial |
South Korea | 101335941 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Axsome Malta Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1890684 | 2020/012 | Ireland | ⤷ Try a Trial | PRODUCT NAME: SOLRIAMFETOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY A HYDROCHLORIDE SALT THEREOF; REGISTRATION NO/DATE: EU/1/19/1408 20200120 |
1890684 | SPC/GB20/017 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: SOLRIAMFETOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY A HYDROCHLORIDE SALT THEREOF; REGISTERED: UK EU/1/19/1408 (NI) 20200120; UK PLGB 31626/0003 20200120; UK PLGB 31626/0002 20200120 |
1890684 | 2020C/004 | Belgium | ⤷ Try a Trial | PRODUCT NAME: SOLRIAMFETOL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, BIJ VOORKEUR EEN HYDROCHLORIDE ZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: EU/1/19/1408 20200120 |
1890684 | 301037 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: SOLRIAMFETOL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, BIJ VOORKEUR HET HYDROCHLORIDEZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/19/1408 20200120 |
1890684 | 20C1014 | France | ⤷ Try a Trial | PRODUCT NAME: SOLRIAMFETOL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, DE PREFERENCE UN SEL DE CHLORHYDRATE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/19/1408 20200120 |
1890684 | 122020000015 | Germany | ⤷ Try a Trial | PRODUCT NAME: SOLRIAMFETOL ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON, BEVORZUGT EIN HYDROCHLORIDSALZ DAVON.; REGISTRATION NO/DATE: EU/1/19/1408 20200116 |
1890684 | CR 2020 00016 | Denmark | ⤷ Try a Trial | PRODUCT NAME: SOLRIAMFETOL ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, FORTRINSVIS ET HYDROCHLORIDSALT DERAF; REG. NO/DATE: EU/1/19/1408 20200120 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.